Rendie E. McHenry

2.0k citations
37 papers · 1.4k · 1 hit paper · h-index 18

Impact in

  • Infectious Diseases top 2%
    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • Viral gastroenteritis research and epidemiology
    • SARS-CoV-2 detection and testing
  • Modeling and Simulation top 2%
    • COVID-19 epidemiological studies

Papers in

  • Infectious Diseases 16
    • SARS-CoV-2 and COVID-19 Research 10
    • COVID-19 Clinical Research Studies 7
    • Viral gastroenteritis research and epidemiology 6
    • SARS-CoV-2 detection and testing 3
  • Epidemiology 18
    • Respiratory viral infections research 9
    • Influenza Virus Research Studies 6
    • Sepsis Diagnosis and Treatment 3
Co-authors
Natasha Halasa (17 shared papers)James D. Chappell (8 shared papers)Daniel C. Payne (4 shared papers)Suman R. Das (2 shared papers)Meghan H. Shilts (2 shared papers)Oscar Gilberto Gomez-Duarte (2 shared papers)Kathryn M. Edwards (3 shared papers)Zaid Haddadin (7 shared papers)
Journals
MMWR Morbidity and Mortality Weekly Report (6 papers)Clinical Infectious Diseases (6 papers)The Journal of Infectious Diseases (3 papers)Hospital Pediatrics (2 papers)Infectious Diseases and Therapy (2 papers)
Partner nations
United StatesFranceJordan

In The Last Decade

Rendie E. McHenry

36 papers receiving 1.4k citations

Rendie E. McHenry's Hit Papers

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 2021 · 330 citations
3300+1+3Years since publication100200300
What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

  1. 2021 MMWR Morbidity and Mortality Weekly Report

Peers

Rendie E. McHenry
Comparison fields: 5 of 85
  • Infectious Diseases 822
  • Modeling and Simulation 136
  • Health 198
  • Epidemiology 290
  • Molecular Medicine 35
Replace Wing‐Kin To with:
Wing‐Kin To Hong Kong
Melissa L. Arvay United States
Ferit Kuşçu Türkiye
İlkay Karaoğlan Türkiye
Awa Traoré United States
Ana Navascués Spain
Uğur Önal Türkiye
Dean Ironmonger United Kingdom
Corinne Holtzman United States
Deborah Steensels Belgium
Rendie E. McHenry relative to Wing‐Kin To Hong Kong Wing‐Kin To's profile →
Citations per field
00.5×2×4×6.3×
Wing‐Kin To · 1×
Citations per year

Countries citing papers authored by Rendie E. McHenry

Since Specialization
Citations

This map shows the geographic impact of Rendie E. McHenry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rendie E. McHenry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rendie E. McHenry more than expected).

Fields of papers citing papers by Rendie E. McHenry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rendie E. McHenry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rendie E. McHenry. The network helps show where Rendie E. McHenry may publish in the future.

Co-authors

The 25 scholars most cited alongside Rendie E. McHenry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rendie E. McHenry Line = papers co-authored together Rendie E. McHenry links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
MMWR Morbidity and Mortality Weekly Report ·Wesley H. Self, Mark W. Tenforde, Jillian P. Rhoads, Manjusha Gaglani, Adit A. Ginde, David J. Douin, Samantha M. Olson, H. Keipp Talbot
Hit paper breakdown →		2021330
2
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020
MMWR Morbidity and Mortality Weekly Report ·Wesley H. Self, Mark W. Tenforde, William B. Stubblefield, Leora R. Feldstein, Jay S. Steingrub, Nathan Ivan Shapiro, Adit A. Ginde, Matthew E. Prekker
2020165
3
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
MMWR Morbidity and Mortality Weekly Report ·Mark W. Tenforde, Wesley H. Self, Eric A. Naioti, Adit A. Ginde, David J. Douin, Samantha M. Olson, H. Keipp Talbot, Jonathan Dale Casey
2021157
4
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020
MMWR Morbidity and Mortality Weekly Report ·Wesley H. Self, Mark W. Tenforde, William B. Stubblefield, Leora R. Feldstein, Jay S. Steingrub, Nathan Ivan Shapiro, Adit A. Ginde, Matthew E. Prekker
2020100
5
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021
MMWR Morbidity and Mortality Weekly Report ·Mark W. Tenforde, Manish M. Patel, Manjusha Gaglani, Adit A. Ginde, David J. Douin, H. Keipp Talbot, Jonathan Dale Casey, Nicholas M. Mohr
202279
6
Prevention of Influenza Hospitalization Among Adults in the United States, 2015–2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)
The Journal of Infectious Diseases ·Jill M. Ferdinands, Manjusha Gaglani, Emily Toth Martin, Don Middleton, Arnold Monto, Fernanda P. Silveira, H. Keipp Talbot, Richard Kent Zimmerman
201861
7
Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020
PEDIATRICS ·Aaron T. Curns, Brian Rha, Joana Y Lively, Leila C. Sahni, Janet A. Englund, Geoffrey A. Weinberg, Natasha Halasa, Mary Allen Staat
202452
8
Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022
MMWR Morbidity and Mortality Weekly Report ·Diya Surie, Levi N. Bonnell, Katherine Adams, Manjusha Gaglani, Adit A. Ginde, David J. Douin, H. Keipp Talbot, Jonathan Dale Casey
202245
9
Multiple Introductions and Antigenic Mismatch with Vaccines May Contribute to Increased Predominance of G12P[8] Rotaviruses in the United States
Journal of Virology ·Kristen M. Ogden, Yi Tan, Asmik Akopov, Laura S Stewart, Rendie E. McHenry, Christopher Fonnesbeck, Bhinnata Piya, Maximilian H. Carter
201841
10
The Changing Landscape of Pediatric Viral Enteropathogens in the Post–Rotavirus Vaccine Era
Clinical Infectious Diseases ·Natasha Halasa, Bhinnata Piya, Laura S Stewart, Herdi Kurnia Rahman, Daniel C. Payne, Amy M. Woron, Linda S. Thomas, Lisha Constantine-Renna
202041
11
Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children
Journal of the Pediatric Infectious Diseases Society ·Shamim Islam, Rangaraj Selvarangan, Neena Kanwar, Rendie E. McHenry, James D. Chappell, Natasha Halasa, Mary Elizabeth Wikswo, Daniel C. Payne
201739
12
Metatranscriptomics to characterize respiratory virome, microbiome, and host response directly from clinical samples
Cell Reports Methods ·Seesandra V. Rajagopala, Nicole Bakhoum, Suman Pakala, Meghan H. Shilts, Christian Rosas‐Salazar, Annie Mai, Helen H. Boone, Rendie E. McHenry
202137
13
Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023
Clinical Infectious Diseases ·Nathaniel M. Lewis, Yuwei Zhu, Ithan D. Peltan, Manjusha Gaglani, Tresa McNeal, Shekhar A Ghamande, Jay S. Steingrub, Nathan Ivan Shapiro
202329
14
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022
Clinical Infectious Diseases ·Noah Kojima, Katherine Adams, Wesley H. Self, Manjusha Gaglani, Tresa McNeal, Shekhar A Ghamande, Jay S. Steingrub, Nathan Ivan Shapiro
202327
15
Enteropathogenic and enteroaggregative E. coli in stools of children with acute gastroenteritis in Davidson County, Tennessee
Diagnostic Microbiology and Infectious Disease ·Monique A. Foster, Junaid Iqbal, Chengxian Zhang, Rendie E. McHenry, Brent E. Cleveland, Yesenia Carolina Romero-Herazo, Chris Fonnesbeck, Daniel C. Payne
201527
16
Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults
Clinical Infectious Diseases ·Kailey Hughes, Donald B. Middleton, Mary Patricia Nowalk, Goundappa K. Balasubramani, Emily Toth Martin, Manjusha Gaglani, H. Keipp Talbot, Manish M. Patel
202027
17
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
The Journal of Infectious Diseases ·Nathaniel M. Lewis, Eric A. Naioti, Wesley H. Self, Adit A. Ginde, David J. Douin, H. Keipp Talbot, Jonathan Dale Casey, Nicholas M. Mohr
202119
18
Respiratory Virus Surveillance in Infants across Different Clinical Settings
The Journal of Pediatrics ·Zaid Haddadin, Danielle A. Rankin, Loren P. Lipworth, Mina Suh, Rendie E. McHenry, Anna Blozinski, Seifein Salib George, Kailee N Fernandez
202119
19
Pneumonia Severity in Children: Utility of Procalcitonin in Risk Stratification
Hospital Pediatrics ·Laura F. Sartori, Yuwei Zhu, Carlos Gabriel Grijalva, Krow Ampofo, Per Hans Gesteland, Jakobi A. Johnson, Rendie E. McHenry, Donald H. Arnold
202117
20
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial
Clinical Infectious Diseases ·Jennifer E. Schuster, Lubna Hamdan, Daniel E. Dulek, Carrie Lynn Kitko, Einas Batarseh, Zaid Haddadin, Laura S Stewart, Anna L. Stahl
202313

About Rendie E. McHenry

Rendie E. McHenry is a scholar working on Infectious Diseases, Epidemiology, Health, Cardiology and Cardiovascular Medicine and Modeling and Simulation, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (10 papers), Respiratory viral infections research (9 papers), COVID-19 Clinical Research Studies (7 papers), Viral gastroenteritis research and epidemiology (6 papers), Influenza Virus Research Studies (6 papers), Vaccine Coverage and Hesitancy (5 papers), SARS-CoV-2 detection and testing (3 papers) and Sepsis Diagnosis and Treatment (3 papers). The work is most often cited by research in Infectious Diseases (822 citations), Modeling and Simulation (136 citations), Health (198 citations), Epidemiology (290 citations) and Molecular Medicine (35 citations). Rendie E. McHenry has collaborated with scholars based in United States, France and Jordan. Frequent co-authors include Natasha Halasa, James D. Chappell, Daniel C. Payne, Suman R. Das, Meghan H. Shilts, Oscar Gilberto Gomez-Duarte, Kathryn M. Edwards, Zaid Haddadin, Danielle A. Rankin and Mary Elizabeth Wikswo. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Clinical Infectious Diseases, The Journal of Infectious Diseases, Hospital Pediatrics and Infectious Diseases and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wing‐Kin ToBreakdown of academic impact, for papers by Melissa L. ArvayBreakdown of academic impact, for papers by Ferit KuşçuBreakdown of academic impact, for papers by İlkay KaraoğlanBreakdown of academic impact, for papers by Awa TraoréBreakdown of academic impact, for papers by Ana NavascuésBreakdown of academic impact, for papers by Uğur ÖnalBreakdown of academic impact, for papers by Dean IronmongerBreakdown of academic impact, for papers by Corinne HoltzmanBreakdown of academic impact, for papers by Deborah Steensels